Network medicine framework for identifying drug-repurposing opportunities for COVID-19

Mostrar otras versiones (1)

The COVID-19 pandemic has highlighted the need to quickly and reliably prioritize clinically approved compounds for their potential effectiveness for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Here, we deployed algorithms relying on artificial intelligence, network diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Morselli Gysi, Deisy, do Valle, Ítalo, Zitnik, Marinka, Ameli, Asher, Gan, Xiao, Varol, Onur, Ghiassian, Susan Dina, Patten, J. J., Davey, Robert A., Loscalzo, Joseph, Barabási, Albert-László
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2021
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126852/
https://www.ncbi.nlm.nih.gov/pubmed/33906951
http://dx.doi.org/10.1073/pnas.2025581118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126852/
https://www.ncbi.nlm.nih.gov/pubmed/33906951
http://dx.doi.org/10.1073/pnas.2025581118

Ejemplares similares